“…Doses were selected based on reported ranges that produced intended pharmacological effects but were below levels found to cause analogous unwanted effects observed in clinical use. All drugs have plasma half-lives that fall within the timing of behavioral training ( Jaillon, 1980 ; Chae et al, 2013 ; Tian et al, 2019 ). Groups received motor training paired with VNS and daily injections of oxybutynin chloride (10 mg/kg, s.c., Fisher Scientific, Hampton, NH, United States – 18604931), prazosin hydrochloride (5 mg/kg, s.c., Fisher Scientific, Hampton, NH, United States – AAJ61712MD), duloxetine (20 mg/kg, s.c., Fisher Scientific, Hampton, NH, United States – D42231G), or saline (s.c.).…”